ArticlebioRxiv : the preprint server for biology2025

KRAS withdrawal in Cholangiocarcinoma leads to immune infiltration and tumor regression.

Youwei Qiao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.